Gene · 151888
Papers3,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes. | Br J Cancer | 2026 | 42800812 | PubTator, text mining | PubMed |
| Mutant HVEM in lymphoma disrupts BTLA and CD160 regulation of anti-tumor signaling. | Front Immunol | 2026 | 42798506 | PubTator, text mining | PubMed |
| Molecular Architecture and Clinical Landscape of Immune Checkpoint Receptors and Ligands. | Antibodies (Basel) | 2026 | 42776797 | PubTator, text mining | PubMed |
| Beyond PD-L1/PD-1: expression of PVR/TIGIT and TNFRSF14/BTLA axes in response to Helicobacter pylori and in gastric cancer lesions. | Immunohorizons | 2026 | 42772936 | PubTator, text mining | PubMed |
| Role of BTLA in ovarian cancer and its clinical prognostic significance based on multi-omics analysis. | J Ovarian Res | 2026 | 42754905 | PubTator, text mining | PubMed |
| A multi-omics integrative analyses reveals CYBB-mediated apoptotic and immune dysregulation as a key target of berberine in diffuse large B-cell lymphoma. | Front Pharmacol | 2026 | 42730162 | PubTator, text mining | PubMed |
| STC1 is associated with tumor progression and suppressive niches in laryngeal squamous cell carcinoma. | Transl Cancer Res | 2026 | 42724726 | PubTator, text mining | PubMed |
| Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis. | Front Bioinform | 2026 | 42656703 | PubTator, text mining | PubMed |
| Elevated BTLA Expression Correlates with an Immunosuppressive Microenvironment and Defines Dysfunctional Circulating T Cells in Human Glioblastoma. | Med Sci (Basel) | 2026 | 42646567 | PubTator, text mining | PubMed |
| The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B. | Front Immunol | 2026 | 42638743 | PubTator, text mining | PubMed |
| CD161 serves as a prognostic biomarker and predicts immunotherapy response in head and neck squamous cell carcinoma. | Front Immunol | 2026 | 42630167 | PubTator, text mining | PubMed |
| Anti-4CB1: A Novel Selective HVEM-Blocking Antibody Enhancing T-Cell and Macrophage Immunity Against Solid Tumors. | Mol Cancer Ther | 2026 | 42617197 | PubTator, text mining | PubMed |
| Admission CD4+ T cell BTLA expression and its association with infection risk and respiratory outcomes in sepsis. | Front Cell Infect Microbiol | 2026 | 42609383 | PubTator, text mining | PubMed |
| Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1. | Int J Mol Sci | 2026 | 42511569 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Therapeutic Response of Diffuse Large B Cell Lymphoma Genetic Subtypes. | Annu Rev Cancer Biol | 2026 | 42487683 | PubTator, text mining | PubMed |
| CD244 overexpression indicates NK cell dysfunction and tumor progression in diffuse large B-cell lymphoma. | Front Immunol | 2026 | 42483169 | PubTator, text mining | PubMed |
| Integrated hypoxia and metabolic gene signature to predict clinical outcomes and therapeutic vulnerabilities in lung adenocarcinoma. | J Thorac Dis | 2026 | 42444878 | PubTator, text mining | PubMed |
| Dynamics of immune-checkpoint regulators and inflammatory cytokines and chemokines associated with preterm birth before and after cervical cerclage. | Front Immunol | 2026 | 42416065 | PubTator, text mining | PubMed |
| A novel mitochondrial-related gene signature for assessing the tumor immune microenvironment and predicting prognosis in human glioma. | Discov Oncol | 2026 | 42334668 | PubTator, text mining | PubMed |
| Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted Hepatocarcinogenesis. | J Hepatocell Carcinoma | 2026 | 42326610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/151888/papers